APG Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
137,510
+37,265
+37% +$3.27M 0.03% 379
2026
Q1
$7.87M Sell
100,245
-16,266
-14% -$1.49M 0.02% 380
2025
Q4
$8.92M Sell
116,511
-2,806
-2% -$266K 0.03% 368
2025
Q3
$10M Buy
119,317
+478
+0.4% +$47.4K 0.03% 351
2025
Q2
$9.23M Buy
118,839
+920
+0.8% +$89K 0.03% 373
2025
Q1
$12.4M Sell
117,919
-7,081
-6% -$758K 0.04% 320
2024
Q4
$12.8M Buy
125,000
+111,036
+795% +$11.9M 0.04% 337
2024
Q3
$1.35M Sell
13,964
-162,765
-92% -$17.8M 0.01% 347
2024
Q2
$17.9M Buy
176,729
+19,811
+13% +$2.34M 0.03% 341
2024
Q1
$19.2M Sell
156,918
-10,229
-6% -$1.28M 0.03% 347
2023
Q4
$18.4M Sell
167,147
-7,797
-4% -$870K 0.04% 334
2023
Q3
$19.6M Sell
174,944
-18,117
-9% -$2.3M 0.04% 326
2023
Q2
$25.8M Sell
193,061
-3,426
-2% -$466K 0.05% 303
2023
Q1
$23.4M Sell
196,487
-21,665
-10% -$2.72M 0.05% 327
2022
Q4
$27.8M Buy
218,152
+178,420
+449% +$20.7M 0.05% 331
2022
Q3
$4.24M Buy
39,732
+13,418
+51% +$1.47M 0.01% 458
2022
Q2
$2.64M Buy
26,314
+17,109
+186% +$2.03M 0.01% 509
2022
Q1
$1.06M Sell
9,205
-8,001
-47% -$964K ﹤0.01% 675
2021
Q4
$1.87M Buy
17,206
+2,369
+16% +$310K ﹤0.01% 595
2021
Q3
$1.82M Sell
14,837
-4,326
-23% -$636K ﹤0.01% 637
2021
Q2
$2.52M Sell
19,163
-6,592
-26% -$1.07M ﹤0.01% 622
2021
Q1
$3.41M Sell
25,755
-95,264
-79% -$14.8M 0.01% 619
2020
Q4
$14.8M Sell
121,019
-10,087
-8% -$1.42M 0.02% 500
2020
Q3
$14.8M Sell
131,106
-8,446
-6% -$1.1M 0.03% 502
2020
Q2
$14.4M Sell
139,552
-9,286
-6% -$1.07M 0.03% 481
2020
Q1
$14.6M Buy
148,838
+98,002
+193% +$12.8M 0.03% 472
2019
Q4
$6.58M Sell
50,836
-22,534
-31% -$3.11M 0.01% 657
2019
Q3
$8.97M Sell
73,370
-1,950
-3% -$252K 0.01% 582
2019
Q2
$7.56M Buy
75,320
+16,995
+29% +$1.99M 0.01% 570
2019
Q1
$6.44M Hold
58,325
0.01% 568
2018
Q4
$5.14M Sell
58,325
-7,931
-12% -$892K 0.01% 557
2018
Q3
$7.28M Buy
66,256
+824
+1% +$98K 0.01% 546
2018
Q2
$6.06M Hold
65,432
0.01% 568
2018
Q1
$5.63M Hold
65,432
0.01% 561
2017
Q4
$6.38M Buy
65,432
+1,030
+2% +$116K 0.01% 575
2017
Q3
$7.32M Buy
64,402
+12,257
+24% +$1.41M 0.01% 570
2017
Q2
$6.5M Sell
52,145
-86,175
-62% -$10.2M 0.01% 547
2017
Q1
$16.4M Sell
138,320
-89,759
-39% -$10.2M 0.03% 443
2016
Q4
$21.7M Sell
228,079
-71,694
-24% -$7.68M 0.04% 405
2016
Q3
$37.8M Sell
299,773
-48,719
-14% -$6.02M 0.07% 335
2016
Q2
$40.7M Buy
348,492
+28,737
+9% +$3.25M 0.08% 298
2016
Q1
$33.1M Buy
319,755
+109,562
+52% +$10.6M 0.07% 320
2015
Q4
$20.9M Sell
210,193
-31,469
-13% -$3.08M 0.05% 371
2015
Q3
$22M Buy
241,662
+6,753
+3% +$677K 0.05% 362
2015
Q2
$24.9M Hold
234,909
0.05% 382
2015
Q1
$26.8M Sell
234,909
-5,334
-2% -$609K 0.06% 354
2014
Q4
$26.5M Buy
240,243
+6,060
+3% +$639K 0.05% 363
2014
Q3
$22.9M Buy
234,183
+4,196
+2% +$413K 0.05% 385
2014
Q2
$23.2M Buy
229,987
+34,837
+18% +$3.4M 0.05% 368
2014
Q1
$17.9M Buy
195,150
+17,334
+10% +$1.6M 0.05% 369
2013
Q4
$16.1M Sell
177,816
-247,815
-58% -$21.4M 0.05% 367
2013
Q3
$33.9M Buy
425,631
+100,877
+31% +$7.94M 0.11% 232
2013
Q2
$23.6M Buy
+324,754
New +$24.3M 0.07% 300

Other funds holding ZBH

APG Asset Management's ZBH Position: Q2 2026 in Review

APG Asset Management increased its Zimmer Biomet (ZBH) stake by 37% in Q2 2026, buying an estimated $3.27M and bringing the position to 137,510 shares worth $10.4M. The position accounts for 0.03% of the portfolio, ranked #379.

APG Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.7M in Q2 2016. 731 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • APG Asset Management held 137,510 shares of Zimmer Biomet worth $10.4M as of Q2 2026.
  • APG Asset Management bought 37,265 Zimmer Biomet shares in Q2 2026, an estimated $3.27M.
  • Zimmer Biomet made up 0.03% of APG Asset Management's portfolio in Q2 2026, its #379 holding.
  • APG Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • APG Asset Management's Zimmer Biomet position peaked at $40.7M in Q2 2016.
  • 731 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.